| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,462 |
5,666 |
$750K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,216 |
5,510 |
$504K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,147 |
2,090 |
$231K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,115 |
2,043 |
$226K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,489 |
1,852 |
$223K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,617 |
1,570 |
$192K |
| 99215 |
Prolong outpt/office vis |
1,005 |
918 |
$156K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,610 |
2,331 |
$103K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,966 |
8,333 |
$89K |
| D1206 |
Topical application of fluoride varnish |
2,932 |
2,888 |
$73K |
| 90658 |
|
2,004 |
1,928 |
$45K |
| 92551 |
|
4,158 |
4,008 |
$39K |
| 90733 |
|
445 |
423 |
$35K |
| 90670 |
|
1,498 |
1,416 |
$33K |
| 96127 |
|
6,407 |
5,704 |
$30K |
| 90647 |
|
1,402 |
1,330 |
$30K |
| 90723 |
|
1,163 |
1,095 |
$25K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,282 |
1,174 |
$25K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
558 |
505 |
$23K |
| 90680 |
|
1,000 |
940 |
$22K |
| 90633 |
|
815 |
789 |
$18K |
| 90710 |
|
658 |
640 |
$15K |
| 81002 |
|
4,649 |
4,379 |
$12K |
| 90657 |
|
526 |
504 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
977 |
899 |
$12K |
| 99173 |
|
4,559 |
4,051 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
952 |
388 |
$9K |
| 90650 |
|
482 |
468 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
117 |
114 |
$6K |
| 96161 |
|
2,509 |
1,617 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,059 |
1,014 |
$3K |
| 0002A |
|
80 |
80 |
$2K |
| 90700 |
|
85 |
79 |
$2K |
| 0001A |
|
84 |
84 |
$2K |
| 90715 |
|
75 |
70 |
$2K |
| 99177 |
|
316 |
313 |
$2K |
| 90696 |
|
66 |
66 |
$2K |
| 90620 |
|
65 |
59 |
$1K |
| 0071A |
|
34 |
34 |
$1K |
| 0072A |
|
34 |
34 |
$1K |
| 99050 |
|
44 |
42 |
$783.60 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
45 |
41 |
$500.00 |
| 99422 |
|
2,025 |
1,860 |
$495.00 |
| 99070 |
|
710 |
635 |
$480.56 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
12 |
$352.52 |
| 90649 |
|
12 |
12 |
$256.08 |
| 90381 |
|
19 |
19 |
$209.51 |
| A7015 |
Aerosol mask, used with dme nebulizer |
13 |
12 |
$90.68 |
| 87400 |
|
12 |
12 |
$84.75 |
| 3074F |
|
50 |
49 |
$0.00 |
| 91307 |
|
99 |
90 |
$0.00 |
| 91300 |
|
218 |
182 |
$0.00 |
| 3078F |
|
51 |
50 |
$0.00 |